Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Rezular – Oral Treatment for IBS

Drug (Brand/Generic)

Rezular (arverapamil)

Company/Licensee

AGI Therapeutics

Therapy Class

Not defined

Product Description

Triple-action intestinal regulator for IBS-D

Current Indication

Diarrhoea-predominant IBS

Market Sector

GI

Development Status

Phase III ARDIS-1 trials failed; other uses being considered
Expand
Close
Close
Close

Go Top